Pamela Provan

The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

Dale W. Garsed, Ahwan Pandey, Sián Fereday et al. · Nature Genetics · 2022 · 113 citations · Full text

Medicine, Immunology, Oncology +16

Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study

Peter Fox, Rosemary L. Balleine, Clara Lee et al. · Clinical Cancer Research · 2016 · 77 citations

Medicine, Oncology, Pharmacology +17

The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer

Nirmala Pathmanathan, Rosemary L. Balleine, Upali W Jayasinghe et al. · Journal of Clinical Pathology · 2014 · 56 citations · Full text

Medicine, Oncology, Breast Oncology +16

Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer

Bonnita Werner, Nicole Laurencia Yuwono, Jennifer Duggan et al. · Gynecologic Oncology · 2021 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +16

Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing

Nirmala Pathmanathan, Pamela Provan, Hema Mahajan et al. · The Breast · 2012 · 29 citations · Full text

Medicine, Oncology, Pathology +14